Long non‑coding RNA RPSAP52 upregulates Timp3 by serving as the endogenous sponge of microRNA‑365 in diabetic retinopathy

Niu,Tongtong; An,Yan; Lv,Tingting; Liu,Dongning

doi:10.3892/etm.2020.9376

Long non‑coding RNA RPSAP52 upregulates Timp3 by serving as the endogenous sponge of microRNA‑365 in diabetic retinopathy

Authors:
- Tongtong Niu
- Yan An
- Tingting Lv
- Dongning Liu
View Affiliations

Affiliations: Department of Ophthalmology, The Fourth People's Hospital of Shenyang, Shenyang, Liaoning 110031, P.R. China
Published online on: October 22, 2020 https://doi.org/10.3892/etm.2020.9376
Article Number: 246

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic retinopathy (DR) is a serious complication of diabetes and the most common metabolic disorder. Recently, long non‑coding (lnc)RNAs have been identified as critical regulators of DR. Ribosomal protein SA pseudogene 52 (RPSAP52) is an oncogenic lncRNA expressed in pituitary tumors. The present study aimed to investigate the functions of RPSAP52 in DR. RPSAP52 levels in the plasma of diabetic patients with or without DR complication was detected. Luciferase reporter assays, RT‑qPCR and western blotting were performed to detect the interaction between RPSAP52 and micro RNA (miR)‑365. Moreover, expression vectors of RPSAP52 and Timp3, as well as miR‑365 mimics were transfected into ARPE‑19 cells exposed to high glucose and the apoptotic cells were detected. The results showed that RPSAP52 was downregulated in patients with DR compared with patients with diabetes without obvious complications. RPSAP52 directly interacted with miR‑365, while overexpression of RPSAP52 and miR‑365 did not affect the expression of one another. In addition, overexpression of RPSAP52 upregulated TIMP metallopeptidase inhibitor 3 (Timp3) in retinal pigment epithelial (RPE) cells. High glucose treatment led to downregulated RPSAP52 and Timp3, but upregulated miR‑365 in RPE cells. Moreover, cell apoptosis analysis identified that overexpression of RPSAP52 and Timp3 led to a decreased apoptotic rate of RPE cells under high glucose treatment. Therefore, it was speculated that RPSAP52 may upregulate Timp3 by serving as the endogenous sponge of miR‑365 in DR to suppress RPE cell apoptosis.

View Figures

View References

1	Dagenais GR, Gerstein HC, Zhang X, McQueen M, Lear S, Lopez-Jaramillo P, Mohan V, Mony P, Gupta R, Kutty VR, et al: Variations in diabetes prevalence in low-, middle-, and high-income countries: Results from the prospective urban and rural epidemiological study. Diabetes Care. 39:780–787. 2016.PubMed/NCBI View Article : Google Scholar
2	Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al: Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 317:2515–2523. 2017.PubMed/NCBI View Article : Google Scholar
3	Oei L, Rivadeneira F, Zillikens MC and Oei EHG: Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep. 13:106–115. 2015.PubMed/NCBI View Article : Google Scholar
4	Lee R, Wong TY and Sabanayagam C: Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2(17)2015.PubMed/NCBI View Article : Google Scholar
5	Nentwich MM and Ulbig MW: Diabetic retinopathy-ocular complications of diabetes mellitus. World J Diabetes. 6:489–499. 2015.PubMed/NCBI View Article : Google Scholar
6	Duh EJ, Sun JK and Stitt AW: Diabetic retinopathy: Current understanding, mechanisms, and treatment strategies. JCI Insight. 2(e93751)2017.PubMed/NCBI View Article : Google Scholar
7	Hampton BM, Schwartz SG, Brantley MA Jr and Flynn HW Jr: Update on genetics and diabetic retinopathy. Clin Ophthalmol. 9:2175–2193. 2015.PubMed/NCBI View Article : Google Scholar
8	Mishra B, Swaroop A and Kandpal RP: Genetic components in diabetic retinopathy. Indian J Ophthalmol. 64:55–61. 2016.PubMed/NCBI View Article : Google Scholar
9	Wihandani DM, Suastika K, Bagiada INA and Malik SG: Polymorphisms of aldose reductase (ALR2) regulatory gene are risk factors for diabetic retinopathy in type-2 diabetes mellitus patients in Bali, Indonesia. Open Ophthalmol J. 12:281–288. 2018.PubMed/NCBI View Article : Google Scholar
10	Liu E, Kaidonis G, McComish BJ, Gillies MC, Abhary S, Essex RW, Chang JH, Pal B, Daniell M, Lake S, et al: MicroRNA-related genetic variants are associated with diabetic retinopathy in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 60:3937–3942. 2019.PubMed/NCBI View Article : Google Scholar
11	Babapoor-Farrokhran S, Jee K, Puchner B, Hassan SJ, Xin X, Rodrigues M, Kashiwabuchi F, Ma T, Hu K, Deshpande M, et al: Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy. Proc Natl Acad Sci USA. 112:E3030–E3039. 2015.PubMed/NCBI View Article : Google Scholar
12	Hewing NJ, Weskamp G, Vermaat J, Farage E, Glomski K, Swendeman S, Chan RV, Chiang MF, Khokha R, Anand-Apte B and Blobel CP: Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci. 54:864–870. 2013.PubMed/NCBI View Article : Google Scholar
13	Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, et al: Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest. 115:3494–3505. 2005.PubMed/NCBI View Article : Google Scholar
14	Wang J, Zhang J, Chen X, Yang Y, Wang F, Li W, Awuti M, Sun Y, Lian C, Li Z, et al: miR-365 promotes diabetic retinopathy through inhibiting Timp3 and increasing oxidative stress. Exp Eye Res. 168:89–99. 2018.PubMed/NCBI View Article : Google Scholar
15	D'Angelo D, Mussnich P, Sepe R, Raia M, Del Vecchio L, Cappabianca P, Pellecchia S, Petrosino S, Saggio S, Solari D, et al: RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins. J Mol Med (Berl). 97:1019–1032. 2019.PubMed/NCBI View Article : Google Scholar
16	National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: A clinician's guide: Updated 2005 edition (no. 7). US Department of Health and Human Services, national institutes of health, national institute on alcohol abuse and alcoholism, 2007. urihttps://my.ireta.org/sites/ireta.org/files/NIAAA_Clinicians_Guide_Helping_Patients.pdfsimplehttps://my.ireta.org/sites/ireta.org/files/NIAAA_Clinicians_Guide_Helping_Patients.pdf.
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
18	Oliveira-Mateos C, Sánchez-Castillo A, Soler M, Obiols-Guardia A, Piñeyro D, Boque-Sastre R, Calleja-Cervantes ME, de Moura MC, Martínez-Cardús A, Rubio T, et al: The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition. Nat Commun. 10(3979)2019.PubMed/NCBI View Article : Google Scholar
19	Leung A and Natarajan R: Long noncoding RNAs in diabetes and diabetic complications. Antioxid Redox Signal. 29:1064–1073. 2018.PubMed/NCBI View Article : Google Scholar
20	Strauss O: The retinal pigment epithelium in visual function. Physiol Rev. 85:845–881. 2005.PubMed/NCBI View Article : Google Scholar
21	Xia T and Rizzolo LJ: Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium. Vision Res. 139:72–81. 2017.PubMed/NCBI View Article : Google Scholar
22	Wang Y, Xu C, Wang Y and Zhang X: MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a. Am J Canc Res. 7:1096–1106. 2017.PubMed/NCBI
23	Qi J, Rice SJ, Salzberg AC, Runkle EA, Liao J, Zander DS and Mu D: MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Cell Cycle. 11:177–186. 2012.PubMed/NCBI View Article : Google Scholar
24	Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y, Du X and Han W: MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting cyclin D1 and Bcl-2. Carcinogenesis. 33:220–225. 2012.PubMed/NCBI View Article : Google Scholar
25	Dunmire JJ, Lagouros E, Bouhenni RA, Jones M and Edward DP: MicroRNA in aqueous humor from patients with cataract. Exp Eye Res. 108:68–71. 2013.PubMed/NCBI View Article : Google Scholar
26	Liang J, Chen M, Hughes D, Chumanevich AA, Altilia S, Kaza V, Lim CU, Kiaris H, Mythreye K, Pena MM, et al: CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases. Cancer Res. 78:6594–6606. 2018.PubMed/NCBI View Article : Google Scholar
27	Weber BH, Vogt G, Pruett RC, Stöhr H and Felbor U: Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet. 8:352–356. 1994.PubMed/NCBI View Article : Google Scholar
28	Li Y, Xu F, Xiao H and Han F: Long noncoding RNA BDNF-AS inversely regulated BDNF and modulated high-glucose induced apoptosis in human retinal pigment epithelial cells. J Cell Biochem. 119:817–823. 2018.PubMed/NCBI View Article : Google Scholar